Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Filings indexed 1,123 across all filing types
Latest filing 2021-01-27 Report Publication Anno…
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Terminy przekazywania raportów okresowych w 2021 roku - Content (PL)
Report Publication Announcement Classification · 100% confidence The document is a formal announcement from the Management Board ("Zarząd") of Mercator Medical S.A. detailing the schedule for the release of its periodic financial reports (annual, quarterly, and semi-annual reports) for the year 2021. It explicitly lists the dates for the 2020 annual report, Q1 2021 report, H1 2021 report, and Q3 2021 report. This type of communication, which announces the timing of future report publications, fits the definition of a Report Publication Announcement (RPA). Although it mentions specific report types (like annual and quarterly reports), the document's primary function is to announce *when* those reports will be published, not to contain the full content of those reports. The document length (2021 chars) is short, supporting the RPA classification over the full report classification (like 10-K or IR).
2021-01-27 Polish
Zestawienie zawartych transakcji
Director's Dealing Classification · 98% confidence The document text consists of a detailed table listing transactions involving the purchase of shares ('nabytych akcji') by an entity ('Mercator Medical S.A.') at specific prices and dates. This structure is characteristic of mandatory regulatory filings reporting personal share transactions by company directors or executives (insider trading reports). Comparing this content to the provided definitions, the 'Director's Dealing' category (Code: DIRS) is the most appropriate fit.
2021-01-27 English
Nabycie akcji własnych i zakończenie odkupu akcji - Content (PL)
Transaction in Own Shares Classification · 100% confidence The document text, written in Polish, explicitly discusses the 'program odkupu akcji własnych' (own share repurchase program) executed by the Issuer ('Emitent'). It details the number of shares acquired, the total price paid, and the resulting total number of treasury shares held. This directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document is a report of the transaction itself, not just an announcement of a report's publication.
2021-01-27 Polish
Zestawienie zawartych transakcji
Director's Dealing Classification · 95% confidence The document text consists of a detailed table showing transactions involving the purchase ('nabytych akcji') of shares by 'Mercator Medical S.A.', including the number of shares, price, total value, and exact transaction timestamps. This structure is characteristic of mandatory regulatory filings disclosing personal share transactions by directors or executives (insider trading reports) or notifications regarding changes in significant shareholdings. Given the granular detail of individual transactions by the issuer itself (which often implies a director/insider transaction filing or a transaction in own shares report), the most fitting category is 'Director's Dealing' (DIRS) or 'Transaction in Own Shares' (POS). Since the table explicitly details the acquisition of shares with specific prices and dates, it strongly aligns with the reporting requirements for insider transactions, which falls under DIRS (Director's Dealing). If the transactions were solely the company buying back its own stock, POS would be appropriate, but the context suggests an insider disclosure based on the typical format of such reports in European markets (often referred to as 'Director's Dealings'). I will classify it as DIRS.
2021-01-25 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 100% confidence The document text, written in Polish, explicitly discusses the acquisition ('nabył') of the company's own shares ('akcji własnych') as part of a share repurchase program ('programu odkupu akcji własnych'). It details the number of shares acquired, the total price paid, and the resulting percentage of the share capital held as treasury stock. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code POS is the most appropriate match.
2021-01-25 Polish
Zestawienie transakcji nabycia akcji
Transaction in Own Shares Classification · 98% confidence The document text consists of a detailed table showing transactions involving the purchase ('nabytych akcji' - acquired shares) of Mercator Medical S.A. stock by an entity, including the number of shares, price, value, and exact transaction timestamps. This structure is characteristic of mandatory regulatory filings reporting insider transactions or significant share ownership changes. Reviewing the definitions, the category 'Director's Dealing' (DIRS) covers reports of personal share transactions by directors and executives (insider trades). While this specific table format might also align with general major shareholding notifications (MRQ), the granular, time-stamped nature of individual transactions strongly suggests a report of dealings by an insider or related party, fitting best under DIRS. It is not an announcement of a report (RPA/RNS), as it contains the substantive data itself, nor is it a general financial report (10-K, IR, ER).
2021-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.